Edesa Biotech amends equity distribution agreement with RBC for up to $15.4M ATM

Edesa Biotech, Inc.

Amended Equity Distribution Agreement with RBC Capital Markets to sell up to $15.4M additional common shares.
Previously sold 487,228 shares for $2.5M under the prior agreement.
Amendment enables ongoing at-the-market offerings through RBC as sales agent or principal.
Legal opinion from Fasken Martineau DuMoulin LLP regarding share legality attached as exhibit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.